Too many biotech stocks have nice up moves into the FDA meeting & then fall on the positive news, but PCRX may still be a buy on weakness sometime today.
surf1944
Share
Thursday, October 27, 2011 3:39:53 PM
Re: surf1944 post# 23
Post # of 154
PCRX approval tomorrow may get the stock price to $15, a no from the FDA could send it to $5, the risk/reward was too great for me, sold out. I usually always sell prior to an FDA meeting, if the stock had a nice run into the event.